Literature DB >> 34379278

Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials.

Rubaya Yeahia1, Renee L Gennarelli2, Daniel J Morgan3, Deborah Korenstein4,5.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34379278      PMCID： PMC9198137          DOI： 10.1007/s11606-021-07056-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  6 in total

1.  Why does framing influence judgment?

Authors:  Gerd Gigerenzer
Journal:  J Gen Intern Med       Date:  2003-11       Impact factor: 5.128

2.  Better reporting of harms in randomized trials: an extension of the CONSORT statement.

Authors:  John P A Ioannidis; Stephen J W Evans; Peter C Gøtzsche; Robert T O'Neill; Douglas G Altman; Kenneth Schulz; David Moher
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

3.  Reporting of safety results in published reports of randomized controlled trials.

Authors:  Isabelle Pitrou; Isabelle Boutron; Nizar Ahmad; Philippe Ravaud
Journal:  Arch Intern Med       Date:  2009-10-26

4.  Talking about Toxicity - "What We've Got Here Is a Failure to Communicate".

Authors:  Chana A Sacks; Pamela W Miller; Dan L Longo
Journal:  N Engl J Med       Date:  2019-10-10       Impact factor: 91.245

Review 5.  Analysis and reporting of adverse events in randomised controlled trials: a review.

Authors:  Rachel Phillips; Lorna Hazell; Odile Sauzet; Victoria Cornelius
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

6.  Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019.

Authors:  Marissa H Elliott; Joshua J Skydel; Sanket S Dhruva; Joseph S Ross; Joshua D Wallach
Journal:  JAMA Intern Med       Date:  2021-02-01       Impact factor: 21.873
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.